Literature DB >> 6219170

Influence of hypertension on the progression of experimental autologous immune complex nephritis.

S Okuda, K Onoyama, S Fujimi, Y Oh, K Nomoto, T Omae.   

Abstract

In order to determine the influence of hypertension on the progression of chronic glomerulonephritis, we studied the renal lesions in Heymann nephritis (autologous immune complex nephritis) produced in SHR. Nephritic SHR treated by AHD, normal SHR, nephritic WKYR, and normal WKYR served as controls. Induction of Heymann nephritis did not alter the blood pressure in either SHR or WKYR as compared with each untreated control group. Administration of AHD normalized the blood pressure of SHR. Proteinuria, hypoproteinemia, hypercholesterolemia, and reduction in body weight were significantly greater in nephritic SHR than in nephritic SHR treated by AHD or nephritic WKYR, whereas BUN and serum creatinine were unchanged in all the nephritic rats. Histological findings such as glomerular basement membrane thickening, IgG and C3 deposits along capillary walls, and subepithelial electron-dense deposits were similar in all nephritic groups. Glomerular sclerosis and tubulointerstitial changes were more marked in nephritic SHR than in the other nephritic groups. Severe vascular thickening and necrosis, intravascular thrombosis, and perivascular cell infiltration were frequently observed in nephritic SHR. These lesions are characteristic of malignant hypertension. However, they were not found in control SHR, which maintained elevation of blood pressure equivalent to that of nephritic SHR throughout the study. It was concluded that hypertension may aggravate nephritic manifestations such as proteinuria, hypoproteinemia, and hypercholesterolemia but not excretory renal function and that the hypertensive vascular lesions are augmented by Heymann nephritis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6219170

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  7 in total

1.  Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.

Authors:  S Anderson; H G Rennke; B M Brenner
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

2.  Studies of progressive glomerular sclerosis in the rat.

Authors:  S Adler; L J Striker; G E Striker; D T Perkinson; J Hibbert; W G Couser
Journal:  Am J Pathol       Date:  1986-06       Impact factor: 4.307

3.  Experimental glomerulonephritis induced by human IgG in rats.

Authors:  K Yamamoto; T Oite; I Kihara; F Shimizu
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

4.  No aggravation of the course of experimental glomerulonephritis in spontaneously hypertensive rats.

Authors:  H D Stein; R B Sterzel; J D Hunt; R Pabst; M Kashgarian
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

5.  Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.

Authors:  S Anderson; T W Meyer; H G Rennke; B M Brenner
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

Review 6.  Glomerulosclerosis: are we any wiser?

Authors:  A M el Nahas
Journal:  Klin Wochenschr       Date:  1989-09-01

7.  Vascular Hyperactivity in the Rat Renal Aorta Participates in the Association between Immune Complex-Mediated Glomerulonephritis and Systemic Hypertension.

Authors:  Israel Pérez-Torres; Bernardo Moguel-González; Elizabeth Soria-Castro; Verónica Guarner-Lans; María Del Carmen Avila-Casado; Teresa Imelda Fortoul Vander Goes
Journal:  Int J Environ Res Public Health       Date:  2018-06-03       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.